Zacks Investment Research upgraded shares of MARKEL CORP (MKL) from UNDERPERFORM to NEUTRAL on June 10, 2014, with a target price of $647.20.
Markel Corporation markets and underwrites specialty insurance products and programs to a variety of niche markets.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on MARKEL CORP (MKL),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment